Literature DB >> 15717973

Mediators of fibrosis and apoptosis in obstructive uropathies.

Rosalia Misseri1, Kirstan K Meldrum.   

Abstract

Upper urinary tract obstruction, regardless of its cause, often poses a significant clinical challenge to the urologist. Renal cellular and molecular events that occur in response to upper urinary tract obstruction result in a progressive and permanent loss in renal function when left untreated. These pathologic changes include the development of renal fibrosis, tubular atrophy, interstitial inflammation, and apoptotic renal cell death. Several cytokines and growth factors have been identified as major contributors to obstruction-induced renal fibrosis and apoptotic cell death, most notably transforming growth factor-b1 (TGF-b1), angiotensin II, nuclear factor-kB (NF-kB), and tumor necrosis factor-a (TNF-a). This review examines the challenges of upper urinary tract obstruction and the role of these mediators in obstruction-induced renal injury.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15717973     DOI: 10.1007/s11934-005-0083-5

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


  73 in total

1.  Nuclear factor kappaB in proliferation, activation, and apoptosis in rat hepatic stellate cells.

Authors:  A Lang; R Schoonhoven; S Tuvia; D A Brenner; R A Rippe
Journal:  J Hepatol       Date:  2000-07       Impact factor: 25.083

Review 2.  Mechanisms of interstitial fibrosis in obstructive nephropathy.

Authors:  J R Diamond; S D Ricardo; S Klahr
Journal:  Semin Nephrol       Date:  1998-11       Impact factor: 5.299

3.  Selective sensitization to tumor necrosis factor-alpha-induced apoptosis by blockade of NF-kappaB in primary glomerular mesangial cells.

Authors:  H Sugiyama; J S Savill; M Kitamura; L Zhao; E Stylianou
Journal:  J Biol Chem       Date:  1999-07-09       Impact factor: 5.157

4.  Early renal ischemia, with or without reperfusion, activates NFkappaB and increases TNF-alpha bioactivity in the kidney.

Authors:  K K Donnahoo; D R Meldrum; R Shenkar; C S Chung; E Abraham; A H Harken
Journal:  J Urol       Date:  2000-04       Impact factor: 7.450

5.  Renal cellular response to ureteral obstruction: role of maturation and angiotensin II.

Authors:  R L Chevalier; B A Thornhill; J T Wolstenholme
Journal:  Am J Physiol       Date:  1999-07

6.  Expression of adhesion molecules in rat renal cortex during experimental hydronephrosis.

Authors:  S D Ricardo; M E Levinson; M R DeJoseph; J R Diamond
Journal:  Kidney Int       Date:  1996-12       Impact factor: 10.612

7.  Collagen studies in newborn rat kidneys with incomplete ureteric obstruction.

Authors:  A Haralambous-Gasser; D Chan; R G Walker; H R Powell; G J Becker; C L Jones
Journal:  Kidney Int       Date:  1993-09       Impact factor: 10.612

8.  Transforming growth factor-beta receptor types I and II are expressed in renal tubules and are increased after chronic unilateral ureteral obstruction.

Authors:  P M Sutaria; M Ohebshalom; T A McCaffrey; E D Vaughan; D Felsen
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

Review 9.  Effects of obstruction on renal functions.

Authors:  S Klahr; K Harris; M L Purkerson
Journal:  Pediatr Nephrol       Date:  1988-01       Impact factor: 3.714

10.  Transforming growth factor-beta is a potent inhibitor of IL-1 induced protease activity and cartilage proteoglycan degradation.

Authors:  S Chandrasekhar; A K Harvey
Journal:  Biochem Biophys Res Commun       Date:  1988-12-30       Impact factor: 3.575

View more
  22 in total

1.  The effect of epigallocatechin-3-gallate on the renal dysfunction in the obstructed kidney in the rat.

Authors:  Fayez T Hammad; Loay Lubbad
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-09-01

2.  Suramin inhibits renal fibrosis in chronic kidney disease.

Authors:  Na Liu; Evelyn Tolbert; Maoyin Pang; Murugavel Ponnusamy; Haidong Yan; Shougang Zhuang
Journal:  J Am Soc Nephrol       Date:  2011-05-26       Impact factor: 10.121

3.  Clusterin attenuates the development of renal fibrosis.

Authors:  Gwon-Soo Jung; Mi-Kyung Kim; Yun-A Jung; Hye-Soon Kim; In-Sun Park; Bon-Hong Min; Ki-Up Lee; Jung-Guk Kim; Keun-Gyu Park; In-Kyu Lee
Journal:  J Am Soc Nephrol       Date:  2011-11-03       Impact factor: 10.121

Review 4.  The long-term renal effects of short periods of unilateral ureteral obstruction.

Authors:  Fayez T Hammad
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2022-04-15

5.  Role of inflammation in túbulo-interstitial damage associated to obstructive nephropathy.

Authors:  María T Grande; Fernando Pérez-Barriocanal; José M López-Novoa
Journal:  J Inflamm (Lond)       Date:  2010-04-22       Impact factor: 4.981

6.  HSP72 attenuates renal tubular cell apoptosis and interstitial fibrosis in obstructive nephropathy.

Authors:  Haiping Mao; Zhilian Li; Yi Zhou; Zhijian Li; Shougang Zhuang; Xin An; Baiyu Zhang; Wei Chen; Jing Nie; Zhiyong Wang; Steven C Borkan; Yihan Wang; Xueqing Yu
Journal:  Am J Physiol Renal Physiol       Date:  2008-04-16

7.  Dendritic cells facilitate accumulation of IL-17 T cells in the kidney following acute renal obstruction.

Authors:  Xiangyang Dong; Lori A Bachman; Melinda N Miller; Karl A Nath; Matthew D Griffin
Journal:  Kidney Int       Date:  2008-08-13       Impact factor: 10.612

Review 8.  EGFR signaling in renal fibrosis.

Authors:  Shougang Zhuang; Na Liu
Journal:  Kidney Int Suppl (2011)       Date:  2014-11

9.  CTGF siRNA ameliorates tubular cell apoptosis and tubulointerstitial fibrosis in obstructed mouse kidneys in a Sirt1-independent manner.

Authors:  Yunzhuo Ren; Chunyang Du; Li Yan; Jingying Wei; Haijiang Wu; Yonghong Shi; Huijun Duan
Journal:  Drug Des Devel Ther       Date:  2015-07-31       Impact factor: 4.162

10.  Reduced NOV/CCN3 Expression Limits Inflammation and Interstitial Renal Fibrosis after Obstructive Nephropathy in Mice.

Authors:  Pierre-Olivier Marchal; Panagiotis Kavvadas; Ahmed Abed; Chantal Kazazian; Florence Authier; Haruhiko Koseki; Shuichi Hiraoka; Jean-Jacques Boffa; Cécile Martinerie; Christos E Chadjichristos
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.